TAK vs ZTS โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
TAK Captures Institutional Edge (2โ2 Pillars ยท 6โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK) driven by superior Valuation, Momentum & Technical while ZTS counters with relative strength in Growth & Margin, Options & Structure. Fundamentally, TAK trades at 12.7x Forward P/E with 16.6% operating margin (+6.7% YoY revenue) versus ZTS at 13.1x Forward P/E and 37.9% operating margin (-1.3% YoY). In options structure, TAK sits in UNCLASSIFIED (5th %ile IV; Dealer Gamma Walls on Pro) against ZTS sits in SURGE (17th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | TAK | ZTS | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $67.5B | $33.7B | Larger Scale | TAK |
| Trailing P/E Ratio Valuation | N/M | 14.1x | Lower Multiple | ZTS |
| Forward P/E Ratio Valuation | 12.7x | 13.1x | Lower Multiple | TAK |
| Revenue Growth (YoY) Growth | +6.7% | -1.3% | Higher Growth | TAK |
| Operating Margin (TTM) Profitability | 16.6% | 37.9% | Higher Margin | ZTS |
| Net Profit Margin Profitability | 0.9% | 26.4% | Higher Margin | ZTS |
| Return on Equity (ROE) Capital Efficiency | 0.6% | 57.6% | Higher ROE | ZTS |
| 52-Week Range Position Momentum | 97% ($14โ$22) | 23% ($69โ$132) | Stronger Trend | TAK |
| Beta / 30D Volatility Risk Regime | -0.02ฮฒ ยท 22% Vol | 0.53ฮฒ ยท 49% Vol | Lower Realized Risk | TAK |
| Unified Institutional Score Composite Signal | 47.7 / 100 (HOLD) | 47.2 / 100 (HOLD) | Higher Composite | TAK |